Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ELMD NYSE:INFU NASDAQ:SKIN NASDAQ:SURG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeELMDElectromed$24.64-0.5%$22.38$17.73▼$35.56$206.39M0.4783,348 shs47,177 shsINFUInfuSystem$10.17-3.1%$9.52$4.61▼$11.04$207.73M1.79186,301 shs206,179 shsSKINBeauty Health$1.65-1.2%$2.05$0.78▼$2.69$211.80M1.211.05 million shs445,291 shsSURGSurgePays$2.82-1.7%$2.73$1.05▼$3.47$58.64M0.4391,700 shs38,830 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceELMDElectromed-0.52%+0.37%+0.69%+20.14%+14.23%INFUInfuSystem-3.14%-1.83%+0.10%+61.69%+41.84%SKINBeauty Health-1.20%-17.09%-19.51%-21.05%+5.77%SURGSurgePays-1.74%+0.36%+2.92%-14.02%+59.32%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeELMDElectromed$24.64-0.5%$22.38$17.73▼$35.56$206.39M0.4783,348 shs47,177 shsINFUInfuSystem$10.17-3.1%$9.52$4.61▼$11.04$207.73M1.79186,301 shs206,179 shsSKINBeauty Health$1.65-1.2%$2.05$0.78▼$2.69$211.80M1.211.05 million shs445,291 shsSURGSurgePays$2.82-1.7%$2.73$1.05▼$3.47$58.64M0.4391,700 shs38,830 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceELMDElectromed-0.52%+0.37%+0.69%+20.14%+14.23%INFUInfuSystem-3.14%-1.83%+0.10%+61.69%+41.84%SKINBeauty Health-1.20%-17.09%-19.51%-21.05%+5.77%SURGSurgePays-1.74%+0.36%+2.92%-14.02%+59.32%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceELMDElectromed 3.50Strong Buy$36.2547.12% UpsideINFUInfuSystem 3.75Strong Buy$13.5032.74% UpsideSKINBeauty Health 2.00Hold$2.8170.45% UpsideSURGSurgePays 2.00Hold$9.50236.88% UpsideCurrent Analyst Ratings BreakdownLatest SURG, INFU, SKIN, and ELMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/3/2025SURGSurgePaysAscendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$9.00 ➝ $9.509/27/2025SKINBeauty HealthWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025SURGSurgePaysWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/25/2025ELMDElectromedZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy9/22/2025SKINBeauty HealthCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold9/22/2025INFUInfuSystemLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$15.009/22/2025SKINBeauty HealthTD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$2.00 ➝ $2.509/19/2025SKINBeauty HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$3.508/27/2025ELMDElectromedLoop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$36.008/27/2025ELMDElectromedRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$29.00 ➝ $35.008/27/2025ELMDElectromedLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$36.00(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookELMDElectromed$64M3.22$0.60 per share41.36$5.10 per share4.83INFUInfuSystem$139.89M1.49$0.80 per share12.79$2.47 per share4.12SKINBeauty Health$334.30M0.63$0.06 per share26.41$0.41 per share4.02SURGSurgePays$60.88M0.95N/AN/A$0.76 per share3.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateELMDElectromed$5.15M$0.8432.85∞N/A11.34%15.71%13.37%N/AINFUInfuSystem$870K$0.23169.5332.81N/A1.12%2.78%1.41%N/ASKINBeauty Health-$29.10M-$0.28N/AN/AN/A-6.13%-32.82%-2.96%11/11/2025 (Estimated)SURGSurgePays-$45.73M-$2.49N/AN/AN/A-133.85%-333.87%-195.36%11/11/2025 (Estimated)Latest SURG, INFU, SKIN, and ELMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025SURGSurgePays-$0.31-$0.36-$0.05-$0.36$16.14 million$11.52 million8/7/2025Q2 2025SKINBeauty Health-$0.06$0.03+$0.09$0.03$74.67 million$78.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthELMDElectromedN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ASURGSurgePaysN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioELMDElectromedN/A5.104.74INFUInfuSystem0.501.981.59SKINBeauty Health4.915.154.15SURGSurgePays101.871.110.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipELMDElectromed40.82%INFUInfuSystem71.13%SKINBeauty Health93.26%SURGSurgePays6.94%Insider OwnershipCompanyInsider OwnershipELMDElectromed14.00%INFUInfuSystem11.40%SKINBeauty Health41.00%SURGSurgePays30.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableELMDElectromed1608.38 million7.36 millionOptionableINFUInfuSystem41020.43 million19.10 millionOptionableSKINBeauty Health1,030126.82 million74.83 millionOptionableSURGSurgePays4020.43 million14.20 millionOptionableSURG, INFU, SKIN, and ELMD HeadlinesRecent News About These CompaniesAscendiant Capital Markets Raises SurgePays (NASDAQ:SURG) Price Target to $9.50October 5 at 2:27 AM | americanbankingnews.comSurgePays (NASDAQ:SURG) Price Target Raised to $9.50 at Ascendiant Capital MarketsOctober 3, 2025 | marketbeat.comSurgepays Unveils Growth Strategy Amid Stock VolatilityOctober 2, 2025 | aktiencheck.deASurgePays CFO Anthony Evers to Depart by Year-EndOctober 2, 2025 | tipranks.comThomas Hughes | Page 3September 25, 2025 | entrepreneur.comESurgePays (NASDAQ:SURG) Stock Passes Above Two Hundred Day Moving Average - What's Next?September 25, 2025 | marketbeat.comSurgePays (NASDAQ:SURG) Share Price Crosses Above 200 Day Moving Average - Should You Sell?September 17, 2025 | marketbeat.com8 Most Undervalued Telecom Stocks to Invest InSeptember 11, 2025 | insidermonkey.comSurgePays (NASDAQ:SURG) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhySeptember 10, 2025 | marketbeat.comMarket Basket Food Stores Rolls Out Digital Advertising PlatformAugust 28, 2025 | csnews.comCSurgePays Launches ClearLine Across All Market Basket Stores, Driving High-Margin Recurring SaaS Revenue Through Nationwide Retail Media RolloutAugust 28, 2025 | prnewswire.comPhone-in-a-Box Prepaid Service SmartphonesAugust 25, 2025 | csnews.comCAnalysts Have Lowered Expectations For SurgePays, Inc. (NASDAQ:SURG) After Its Latest ResultsAugust 16, 2025 | finance.yahoo.comSurgePays Second Quarter 2025 Earnings: Misses ExpectationsAugust 15, 2025 | finance.yahoo.comSurgePays sees 2025 revenue $75M-$90M vs. $15.09M in 2024August 15, 2025 | msn.comSurgePays Reports Growth and Sets Ambitious Revenue TargetsAugust 14, 2025 | msn.comSurgePays, Inc. (NASDAQ:SURG) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | insidermonkey.comSurgePays, Inc. (SURG) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comSurgePays, Inc. (SURG) Reports Q2 Loss, Lags Revenue EstimatesAugust 13, 2025 | zacks.comSurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026August 13, 2025 | prnewswire.comSurgePays to Host Second Quarter 2025 Financial Results Conference Call on Wednesday, August 13August 5, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesGameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound?By Dan Schmidt | September 22, 2025These 3 Stocks Are Shielded From the AI TakeoverBy Gabriel Osorio-Mazilli | September 15, 2025CrowdStrike Stock Set for Breakout as Agentic AI Demand SurgesBy Chris Markoch | September 17, 20253 Overlooked Value Stocks Set to Surge as Rates DropBy Gabriel Osorio-Mazilli | September 21, 2025NuScale, Rocket Lab Face Heavy Insider Selling After SurgesBy Leo Miller | September 26, 2025SURG, INFU, SKIN, and ELMD Company DescriptionsElectromed NYSE:ELMD$24.64 -0.13 (-0.52%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$24.68 +0.04 (+0.16%) As of 10/7/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.InfuSystem NYSE:INFU$10.17 -0.33 (-3.14%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$10.18 +0.01 (+0.10%) As of 10/7/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Beauty Health NASDAQ:SKIN$1.65 -0.02 (-1.20%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$1.66 +0.02 (+0.91%) As of 10/7/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.SurgePays NASDAQ:SURG$2.82 -0.05 (-1.74%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$2.80 -0.02 (-0.57%) As of 10/7/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector 3 Dividend Aristocrats to Buy Before Year’s End The Juice Is Loose: Why Plug Power's Rally Is Just the Beginning Joby's Stock Rallies as Public Flights Validate Global Game Plan SharkNinja Is Flashing a Buy Signal the Market Is Ignoring Why Semtech Stock Is Rallying After Its NVIDIA Setback Marvell Insiders Buy Shares—Should Investors Follow Suit? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
